Multifunctional Theranostic Nanomedicines in Cancer

Malay K. Das (MPharm, PhD) is a Professor of Pharmaceutics at the Department of Pharmaceutical Sciences, Dibrugarh University, in India. His research interests include novel drug delivery systems, pharmaceutical nanotechnology, nanomedicine, and transdermal and targeted drug delivery systems. He has handled several major research projects sponsored by the DST, DBT, ICMR, UGC, and AICTE. Professor Das has been honored with the prestigious DBT-Biotechnology Overseas Associateship at the University of South Florida, Tampa, United States and the DST-UKIERI Research Award in collaboration with the Institute of Pharmaceutical Sciences, King’s College, London, United Kingdom. He has several publications including peer-reviewed research and review articles in various international journals, as well as chapters in various books published by international publishers.

1. Nanoparticle-based theranostics in cancer 2. Multifunctional nanotheranostics for cancer diagnosis and treatments 3. Multifunctional micellar nanomedicine for cancer therapy 4. Multifunctional theranostic nanomedicine for photoacoustic imaging-guided combination tumor treatment 5. Multifunctional silica nanoparticles as a promising cancer theranostics 6. Multifunctional hypoxia imaging-guided tumor nanotheranostics 7. Blood-brain-barrier crossing nanotheranostics in brain cancer 8. Peptide-drug conjugates in targeted drug delivery to cancer 9. Recent advancement in photonanotheranostics for cancer treatment 10. Smart multifunctional nanosystem: Next generation drug delivery platform for drug resistant breast cancer 11. Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment 12. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy in cancer 13. Nanotargeted radiopharmaceuticals for cancer theranostics 14. Nanoparticle-based radio immune therapy in cancer care 15. Image-guided biodistribution and pharmacokinetic studies of theranostics 16. Technological challenges of theranostics in oncology 17. Theranostic nanoparticles engineered for clinic and pharmaceutics 18. Multifunctional nanoparticles – cost versus benefit of adding targeting and imaging capabilities